机译:工程化多功能纳米药物在骨转移原位模型中同时进行立体定向化学疗法和抑制溶骨作用
Chinese Acad Sci, CAS Key Lab Nanobio Interface, Div Nanobiomed, Suzhou 215123, Peoples R China|Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, CAS Ctr Excellence Brain Sci, i Lab, Suzhou 215123, Peoples R China;
Chinese Acad Sci, CAS Key Lab Nanobio Interface, Div Nanobiomed, Suzhou 215123, Peoples R China|Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, CAS Ctr Excellence Brain Sci, i Lab, Suzhou 215123, Peoples R China;
Chinese Acad Sci, CAS Key Lab Nanobio Interface, Div Nanobiomed, Suzhou 215123, Peoples R China|Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, CAS Ctr Excellence Brain Sci, i Lab, Suzhou 215123, Peoples R China;
Chinese Acad Sci, CAS Key Lab Nanobio Interface, Div Nanobiomed, Suzhou 215123, Peoples R China|Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, CAS Ctr Excellence Brain Sci, i Lab, Suzhou 215123, Peoples R China;
Soochow Univ, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China;
Chinese Acad Sci, CAS Key Lab Nanobio Interface, Div Nanobiomed, Suzhou 215123, Peoples R China|Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, CAS Ctr Excellence Brain Sci, i Lab, Suzhou 215123, Peoples R China;
机译:唑来膦酸在具有混合性骨病变的犬前列腺癌裸鼠模型中减少了骨溶解,但没有骨转移。
机译:仿生纳米胺再加上Neoadjuvant化疗,通过肿瘤微环境重塑来抑制乳腺癌转移
机译:POS-1原位模型作为“成像模型”在体内并同时监测骨肉瘤中肿瘤增殖和骨重塑的相关性
机译:组织工程仿生3D体外模型研究乳腺癌骨转移
机译:分子工程疗法:核因子κB转录控制乳腺癌在骨中的生长以及相关的肿瘤介导的骨溶解。
机译:唑来膦酸可降低犬混合前列腺病变裸鼠模型的溶骨作用但不会降低骨转移
机译:胰腺癌患者来源的原位异种移植(pDOX)裸鼠模型中的转移复发受到新辅助化疗联合荧光引导手术和抗Ca 19-9-缀合荧光团的抑制。
机译:通过LOVaZa和DHa脂肪酸抑制乳腺癌引起的裸鼠骨痛,转移和骨溶解。